fiúàÕ53-3†E4_fiÁ‘W07_‚åŒî.indd
|
|
- ゆたか いさし
- 5 years ago
- Views:
Transcription
1 SLE and CNS Lupus Naoko Ohya, M.D. Department of Rheumatology, Yokohama Seibu Hospital, St. Marianna University School of Medicine NICHIDOKU-IHO Vol. 53 No (2008) Summary Systemic lupus erythematosus (SLE) is a multisystem, autoimmune disease with a broad range of clinical features, and entails neuropsychiatric complications associated with increased morbidity and mortality. Although a variety of diffuse and focal neuropsychiatric symptoms are seen in patients with SLE, it is difficult to differentiate CNS lupus from secondary CNS complications caused by nephritis, hypertension, infection, or medication. In particular, exclusion of steroid psychosis poses difficulty. Abnormal findings in EEG, images like MRI or SPECT, or cerebrospinal fluid (CSF) examination are not specific to CNS lupus. Neuroimaging techniques maximize usefulness of immunological examinations when both are combined. Early diagnosis and treatment assist in mitigating the mortality and morbidity associated with CNS lupus. systemic lupus erythematosus SLE CNS SLECNS ,000 SLE SLE SLE T B SLE 38 DNA Sm
2 4 SLE SS-A RNP the American Collage of Rheumatology ACR 1 SLE 1 SLE SLE PSL mg/Kg/ PSL mg/Kg/ CNS PSL mg/Kg/ 0.5 1g/ 3 SLE CY AZA CyA MMF SLE CNS SLE CNS SLE CNS neuropsychiatric SLE NPSLE SLE SLE
3 10 35 SLE SLE CNS SLE SLE SLE 1999 ACR SLE 19 2 CNS 4 CNS SLE 20 SLE 7 8 SLE SLE antiphospholipid syndrome APS APS APS SLE
4 SLE CNS SLE ACR CNS 80 CNS SLE PSL 40mg/ 85 PSL 40mg/ MRI CNS Hirohata CNS 14 SLE SLE ds-dna Sm SLE SLE DNA CNS SLE CNS Sm P Sm SLE SLE APS MRI MRI MRI 19 SLElupus anticoagulant LACanticardiolipin antibodies acl 2-GPI LAC LAC GPI 20 SLE
5 CNS CNS kDa SLE SLE 22 DNA NR2 NR2 CNS 23 SLE Q IgG index IL-6 IL-8 IFN IgG idex Hirohata 25 CNS CNS SLE IL-6 IL-6 3 CNS glial fibrillary acidic protein GFAP neurofilament triplet protein NFL NFL IL-6 IL-8 origoclonal immunoglobulins GFAP NFLMRI IFN- SLE SLE CNS 80 CNS SLE 60 CT MRI SPECT PET CT CT MRI SPECT MRI CT MRI CNS MRI MRI SLE CNS MRI CNS SLE 9 40 SLE SLE 26 SLE CNS 16 MRI 4 4 focal lesion 2 atrophy 4 focal lesion atrophy2 1 MRI focal lesion Atrophy 2 1
6 CYfocal lesion atrophy 4 3 diffuse 2 akinetic mutism astrocytosis focal lesion p < 0.05 SLE SPECT MRI SLE 2 cm focal lesion MRI SLE 1996 reversible posterior leukoencephalopathy syndrome RPLS Hinchey RPLS RPLS blood brain barrier BBB 28 MRI CNS
7 diffuse type CNS 29 SPECT Sibbit SPECT SPECT MRI SPECT SPECT Kodama 31 SLE20 SPECT 15 SPECT 9 4 SPECT subclinical PET positoron emission tomography SPECT CNS PET 100 MRI 50 MRI PET PET CNS 32 CNS CNS CNS 3 33 CNS PSL 60mg/ 1g/ 3 IgG index IL-6 SLE CY AZA AZA CY IVCY IVCY CNS Barile 36 CNS IVCY IVCY CY A B C D
8 ST CNS SPECT CNS 37 CD20 CNS SLE 38 DNA SLE mm/hr2,400/ L Hb 12.8/ dl PLT 6.2 / L ANA 2,560 CH50 < 10U/mL C3 14mg/dL C4 1mg/dLC1q > 20 g/ml IgG 3,368mg/dL IgA 207mg/dL IgM 303mg/dL ds-dna 640IU/mL RNP 2 Sm 2 SS-A MPO-ANCA LA acl PSL 30mg/ 50mg/ 81mg/dL IgG Index 0.3 MRI 2 FLAIR MCA DWIADC map MRA 3 MCA CNS PSL 60mg/ 3 2 MRI SLE CNS 34 DNA SLE PSL 15mg/ mm/hr 1,900/ L RBC 409 / L PLT 6.9 / L
9 FLAIR MCA DWI ADC map 1 MCA M2 1 M2
10 T2 FLAIR DWIADC map T1 T bil 0.7mg/dL AST 606IU/L ALT 520IU/L LDH 911IU/L ALP 183IU/L GTP 689IU/L M2 ANA 320 CH50 < 10U/mL C3 30mg/dL C4 1mg/dL C1q 5.6 g/ml IgG 2,460mg/dL IgA 566mg/dL IgM 136mg/dL ds- DNA 45.5IU/mL RNP Sm SS-A MPO-ANCA LAC acl 10/ mg/dL IgG Index 0.5 MRI 4 T2 FLAIR T1 DWIADC map CNS PSL 50mg/ 1mg/Kg 2 MRI AZA AZA 300mg PSL 10mg/ SLE MRI 80 CH5017.8U/mL C3 82mg/dL C4 12mg/dL IC Ciq 4.4 g/ml ds-dna 10.0IU/mL 9/3 100IgG Index 0.61 MRI 20mg/ 80 CH50 < 10U/mL C3 60mg/dL C4 5mg/dL IC Ciq 4.4 g/ml ds-dna 56.0IU/mL MRI 5 FLAIR T2 DWI ADC map SLE AZA SLE SLE AZA SLE
11 FLAIRDWI T2 ADC map MRI Raynaud DNA 169U/mL SLE C3 14 C4 3 CH acl LAC PSL 50mg/ 1 IgG IgG index 0.8 MRI CNS CY CY 2 3
12 acrocyanosis CY 1 SLE CNS CNS 1 Hochberg MC: Updating the American Collage of Rheumatology revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum. : 1725, Gladman DD, Urowitz MB: Prognosis, mortality, and morbidity in systemic lupus erythematosus. (In) Wallace DJ, Hahn BH (eds): Dubois Lupus Eryhthematosus, 6th ed. 1255, 2002, Lippincott Williams & Wilkins, Philadelphia 3 Appenzeller S, Cendes F, Costallat LT: Epileptic seizures in systemic lupus erythematosus: Neurology : , ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature: The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndrom. Arthritis Rheum. : , Wong KL, Woo EK, Yu YL, et al: Neurological manifestations of systemic lupus erythematosus: a prospective study. Q J Med : , Hanly JG, McCurdy G, Fougere L, et al: Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol : , Futrell N, Millikan C: Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus. Stroke: : , Mikdashi J, Handwerger B, Langenberg P, et al: Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemic stroke and stroke severity in systemic lupus erythematosus. Stroke. : , Kovacs B, Lafferty TL, Brent LH, et al: Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis: : , Mok CC, Lau CS, Chan EY, et al: Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome. J Rheumatol : , Carbotte RM, Denburg SD, Denburg JA, et al: Cognitive dysfunction in systemic lupus erythematosus is independent of active disease. J Rheumatol : , Denburg SD, Denburg JA, Carbotte RM et al: Cognitive deficits in systemic lupus erythematosus. Rheum Dis Clin North Am : , Hirohata S, Iwamoto S, Miyamoto T, et al: A patient with systemic lupus erythematosus presenting both central nervous system lupus and steroid induced psychosis. J Rheumatol : , Isshi K, Hirohata S: Association of anti-ribosomal P protein antibodies with neuropsychiatric system lupus erythematosus. Arthritis Rheum : , Isshi K, Hirohata S: Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathologenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum : , Herranz MT, Rivier G, Khamashta MA, et al : Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum : , Appenzeller S, Cendes F, Costallat LT: Epileptic seizures in systemic lupus erythematosus. Neurology. : , Lampropoulos CE, Koutroumanidis M, Reynolds PP, et al: Electroencephalography in the assessment of neuropsychiatric manifestations in antiphospholipid syndrome and systemic lupus erythematosus. Arthritis Rheum : , Avcin T, Benseler SM, Tyrrell PN, et al: A followup study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus. Arthritis Rheum : 206-
13 213, Bluestein HG, Williams GW, Steinberg AD: Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med : , Hanson VG, Horowitz M, Rosenbluth D, et al: Systemic lupus erythematosus patients with central nervous system involvement show autoantibodies to a 50-kD neuronal membrane protein. J Exp Med : , DeGiorgio LA, Konstantinov KN, Lee SC, et al: A subset of lupus anti-dna antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med: : , Katsumata Y, Harigai M, Kawaguchi Y, et al: Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferonalpha, IgG index, and Q-albumin. J Rheumatol : , Hirohata S, Miyamoto T: Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum: : , Appenzeller S, Rondina JM, Li LM, et al: Cerebral and corpus callosum atrophy in systemic lupus erythematosus. Arthritis Rheum : , Hinchey J, Chaves C, Appignani B, et al: A reversible posterior leukoencephalopathy syndrome. N Engl J Med : , Reversible posterior leukoencephalopathy syndrome (RPLS) Ishimori ML, Pressman BD, Wallace DJ, et al: Posterior reversible encephalopathy syndrome: another manifestation of CNS SLE? Lupus : , Sibbitt WL Jr, Sibbitt RR,Brooks WM: Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum : , Kodama K, Okada S, Hino T, et al: Single photon emission computed tomography in systemic lupus erythematosus with phychiatric symptoms. J Neurol Neurosurg Psychiatry : , Weiner SM, Otte A, Schumacher M, et al: Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis : , CNS Neuwelt CM, Lacks S, Kaye BR, et al: Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Am J Med : 32-41, Boumpas DT, Yamada H, Patronas NJ, et al: Pulse cyclophosphamide for severe neuropsychiatric lupus. Q J Med Dec : , Barile-Fabris L, Ariza-Andraca R, Olguín-Ortega L, et al: Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis: : , CNS Saito K, Nawata M, Nakayamada S, et al: Successful treatment with anti-cd20 monoclonal antibody (rituximab) of life-threatening refractory systemic lupus erythematosus with renal and central nervous system involvement. Lupus : , Tokunaga M, Saito K, Kawabata D, et al: Efficary of rituximab (anti-cd20) for refractory systemic lupus erythematosus involving the central nervous system. Ann Rheum Dis : , 2007
indd
18 61 1 2011 症例報告 2010 5 13 2010 12 20 A Case of Varicella with Severe Back Pain in a Patient with Systemic Lupus Erythematosus RIE SAITO, KIORI YANO, FUMIKO KATSUSHIMA, HARUYO IWADATE, HIROKO KOBAYASHI,
More information37, 9-14, 2017 : cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin CD 7 Clostridium difficile CD CD associate
37, 9-14, 2017 : 36 2015 8 6 cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin 20 1983 2016 3 CD 7 Clostridium difficile CD CD associated diarrhea : CDAD CD 1,2 PPI 3 1 36 33 2015 8 6 5 5
More information顔面神経麻痺を来したMPO―ANCA 陽性の中耳炎2症例
11367 : MPOANCA MPO ANCA MPOANCA 134EU MPO ANCA 67EU MPOANCA ANCA : MPOANCAANCA antineutrophil cytoplasmic antibody ; ANCA Davies IgG ANCA PR3proteinase3ANCA MPOmyeloperoxidaseANCA Wegener PR3ANCA MPO
More information臨床神経学53-7.indb
53 1 * 100 systemic lupus erythematosus; SLE 1 10 20 SLE SLE Table 1 American College of Rheumatology; ACR SLE SLE 1 SLE SLE neuro-psychiatric SLE; NPSLE anti-phospholipid syndrome; APS NPSLE Table 1 /
More information2 W.T T.S. 70 2 1 238 WBC7400/µl, RBC 386 10 4 /µl, Hb 11.6 g/dl, Ht 36.2%, PLT 25 10 4 /µl AST 19 IU/l, ALT 11 IU/l, LDH 182 IU/l, BUN 15 mg/dl, Cr 0.54 mg/dl, CRP6.83 mg/dl, RF 353.9IU/ml, CCP 28.0IU/ml
More informationDiagnosis of Dementia: Update
10 C A 1 2 Normal SMI MCI Early Dementia B Moderate Dementia 3 Severe Dementia 4 5 D AD, VD, FTD, DLB, PDD Depression Dementia d/t GMC Modifiable risk factors and preventive factors for dementia 6-5 -
More information5 CSF 6 CSF 7 CSF CSF CDV CDV GFAP CSF Pandy test NSE MBP LDH mu/ml 0-5 /µl AST mu/ml CK mu/ml <25 mg/dl<45 mg/dl GLU
CT MRI CSFCSF CSF CSF CSF CSF CSF (cisternal puncture) CSF 20-23G 90 (20-23G) : CSF
More informationGL_尾崎班_D.indd
Circulation Journal Vol. 72, Suppl. IV, 2008 1319 Churg-Strauss ANCA ANCA 1 1 1320 Circulation Journal Vol. 72, Suppl. IV, 2008 ANCA 1 ANCA ANCA 2 Circulation Journal Vol. 72, Suppl. IV, 2008 1321 2 2
More information小児感染免疫第26巻第3号
2014 小児感染免疫 Vol. 26 No. 3 403 45,, nonherpetic acute limbic encephalitisnhale NHALE NMDA NmethylD aspartatetype glutamate receptornmda GluR NHALE NMDA GluR NHALE IgG NMDA GluR MRI 3040 NHALE 12 1 Key words
More information1996 papilloma virus 2001 Bowen AIHA PSL1mg/kg BMA PRCA parvovirus B19 PVB19 DNA PCR PV IgM 4 PVB19 PRCA MAP PVB19 DNA DNA PR
1996 papilloma virus 2001 Bowen2002 12 2003 2 2002 9 10 AIHA PSL1mg/kg BMAPRCA parvovirus B19 PVB19 DNA PCR PV IgM 4PVB19 PRCA MAPPVB19DNA DNA PRCA IVIG;20 50g/ IVIG PVB19AIHA steroid 15 20mg/day 2003
More information_02.indd
30, 11-16, 2010 Z Z score Computed tomography ROC analysis 3 CT 1,2 CT 1/3 3 5 CT CT 6 7,8 MCA ASPECTS Alberta Stroke Programme Early CT Score 4 10 CT ASPECTS 50% 9 Z 10 CT Z CT 10 Z Z Z receiver operating
More informationBUN, CRP K mg/ cm, 49.6 kg, BMI /72 mmhg, 92/ Hb 6.7 g/dl PT-INR CT 1 MRI 2a, b T1 T2 T1 MRI
20 2 2015 1 2 3 85 K CT Abstract A case of renal subcapsular hematoma resulting from trigger point injection under excessive effect of anticoagulant YAMANE Tateki, UMEDA Akira and SHIMAO Hitoshi An 85-year-old
More informationSingle slice helical CT CT 1 2005 1 4 1. CT Anti-Lung Cancer Association: ALCA 1-5) 1993 9 10 ALCA (Nawa 6) ) single slice helical CT 10mm CT 2. 1 (http://www.thoracic-ctscreening.org/jpn/index.html )
More informationWBC 5700 / l Gran 58.5% Lym 29.0% Eosin 0.3% RBC 499x10 6 / l Hb 14.8 g/dl Hct 44.40% PLT 15.3x10 3 / l PT 157% Fbg 616 mg/dl DD 0.99 g/ml GOT GPT LDH
54 2002 3 1992 2002 3 2002 7 2004 1 15 4Kg74.0Kg 1 24 80.6 kg BUN 26.0mg/dl, s-cr 2.3mg/dl, 3+ 1 27 40 /34 174.3 cm 80.6 kg 1 10kg36.8 120/70 mmhg 88 / 14 / fibrinogen 616 mg/dl, TP 3.6 g/dl, Alb 1.4 g/dl,
More information82 CQ2 医療機関受診時にけいれん発作が続いている場合, 最初に試みるべき治療は何か 1 PubMed #1 Status Epilepticus/therapy Majr OR status epilepticus TI AND therap TIAB OR treatment TIAB NO
81 文献検索式 CQ1 CQ14 CQ1 CQ1 けいれん発作に対して重積化を防ぐために早期に治療介入することは必要か 1 PubMed 1980 1 2015 12 2016 4 30 #1 Status Epilepticus/therapy Majr OR status epilepticus TI AND therap TIAB OR treatment TIAB OR prevent TIAB
More informationsick contact1l
Clinical Question 2017 年 5 月 15 日 分野 : 内分泌テーマ : 治療 19 14 15 18 sick contact1l 170cm/68.8kg, GCSE1V1M5, HR: 120/min, BP: 104/60mmHg, RR: 30/min, SpO 2 : 96%, BT: 38.0 WBC Hb PLT CRP Cr BUN 23400 15.0 35.5
More informationFig. 1 Clinical findings and extent of inflammation area in female urethrocystitis Fig. 2 Classification and distribution of female patients with blad
Key words: Female with bladder irritability, Subjective symptoms, Pyuria, Bacteriuria Fig. 1 Clinical findings and extent of inflammation area in female urethrocystitis Fig. 2 Classification and distribution
More information1 2 2 ANCA pouci immune IgG C3 ANCA 68 '01 '02 7 UN 14mg/dl, Cr 0.7 mg/dl, -, - ' UN 45mg/dl, Cr 2.4 mg/dl, Ht 29.5%, 4+, cm 61
1 2 2 ANCApouci immune IgG C3 ANCA 68 '01 '02 7 UN 14mg/dl, Cr 0.7 mg/dl, -, - '03 2 3 31 UN 45mg/dl, Cr 2.4 mg/dl, Ht 29.5%, 4+, 3+ 4 14 156.0 cm 61.5 kg 36.9 158/92 mmhg 90 1. ANCA 2. 3. IgG4 deposit
More information日本呼吸器学会雑誌第48巻第6号
Fig.1 Cutaneousfindingsandpathologicalfindingsofatransbronchiallungbiopsy(TBLB)andlichenifiedeczemaoftherightforearm.Thepatienthadlichenifiedeczemaonhisextremitiesandbodytrunk (1a:rightforearm,1b:leftthigh).Therewasinfiltrationoftheinflammatorylymphocytes,edemaandabrasioninthetype2alveolarepithelium
More informationValganciclovir 1 CMV valganciclovir VGCV CMV IgM CMV-DNA CMV 34 VGCV 2 1 CMV CMV ganciclovir valganciclovir MRI cytomegaloviru
2012445559 55 Valganciclovir 1 CMVvalganciclovirVGCV 1 21 5 CMV IgM CMV-DNA CMV 34 VGCV 2 1 CMV CMV ganciclovirvalganciclovir MRI cytomegalovirus; CMV TORCH CMV 1 CMV valganciclovirvgcv 21 2 1 1 2 23 37
More information小児感染免疫第25巻第2号
Vol. 25No. 2145 1,2 1 1 1 1 2 2 2 TFLX 9 TFLX 450 mg16.6 mgkg TFLX 30 kg TFLX 2009 10 TFLX 1 1 2 3,4 TFLX 9 22 6 18 19 TFLX 450 mg150 mg 1 1 1 3 16.6 mgkg 20 20 0 21 3 135.0 cm0.1 S.D. 27.0 kg0.8 S.D.
More information44 SLE PVB19 SLE IgM IgG PCR PVB19 IgM dsdna SLE PVB19 Lupus mimickers 8 PVB19 SLE Gottron cm 2.0SD 28.0 kg 1.1SD
33 1 43 50 2018 43 Lupus mimickers 1 2 1 2 1 2 3 1 2 1 2 3 11 SLE American College of Rheumatology ACR) SLE ATP B19 PVB19 IgM PVB19 Lupus mimickers ITP 2 SLE ATP PVB19 ITP PCR PVB19 IgM IgG 8 SLE PVB19
More information特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案)
VOL.51 NO.6 JUNE 2003 JUNE 2003 9) Niederman MS et al: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention.
More informationA indd
184 Dementia Japan 24 : 184-190, 2010 原著 要旨 davf davf 128 6 MRI SPECT 12% S 25% Characteristic of a dural arteriovenous fistulae (davf)producing symptoms of dementia Sachio Suzuki 1, Akira Kurata 1, Satoshi
More information/12/28 UP 3+, TP 4.2g/dl, Alb 1.9g/dl PSL 50mg/day 1/17 PSL 45mg/day PSL 2006/4/4 PSL 30mg/day mpsl mpsl1000mg 3 2 5/ :90 / :114/64 mmhg
17 2005/12/28 UP 3+, TP 4.2g/dl, Alb 1.9g/dl PSL 50mg/day 1/17 PSL 45mg/day PSL 2006/4/4 PSL 30mg/day mpsl mpsl1000mg 32 5/8 36.1 :90 /:114/64 mmhg 166.2 cm64.3 kg 3.9 g/dl 1.6 g/dl 382 mg/dl 408 mg/dl
More informationindd
60 4 2010 197 症例報告 1 1 1 2 2 2 2 3 4 1 2 3 4 2010 7 27 2010 9 24 Case of a Young Adult Male Complicated with Ischemic Colitis EMI OGATA 1, TAKERU WAKATSUKI 1, HIROAKI SAKAMOTO 1, NATSUMI SAKAMOTO 2, OSAMU
More informationTable 1 Isolated venous thrombi in soleal muscle by ultrasonography US finding Acute Chronic Total No. Early stage non-retracted slightl
Online publication October 8, 2010 原 著 第 50 回総会座長推薦論文 孤立性ひらめ筋内静脈血栓と抗核抗体との関連 1 2 要旨 : 89 116 D 3 30 70 63 26 100 J Jpn Coll Angiol, 2010, 50: 417 422 Key words: isolated soleal venous thrombi, recurrent
More information1. Paul, L. W. and Juhl, H.: The Essentials of Roentgen Interpretation. Harper & Row, Publishers. pp. 339-355, 1972. 2. Norman, D., Diamond, C. and Boyd, D.: Relative detectability of intracranial calcifications
More informationNSIPとUCTD(HP用).ppt
NSIP (- NSIP) (Non-) NSIP (Kinder) Retrospective () (Non-) (Kinder) 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 1. 2. RA 3. Scl-70 4. SS-ASS-B 5. Jo-1 6. (>), CRP NSIP 62 6PM/DM* 9 47 *PM/DM: Polymyositis/dermatomyositis
More information1) Steinbrocker, O.: The shoulder-hand syndrome in reflex dystrophy of the upper ex- tremity, Ann. Intern. Med., 29: 22, 1948. 5) Greenfield, A. D. M., Whitney, R. J. and Mowbray, J. F.: Methods for the
More informationClinical Study of Effect of Intrathecal Use of Alpha-tocopherol on Chronic Vasospasm Hirotoshi Sano, Motoi Shoda, Youko Kato, Kazuhiro Katada, Youichi
Clinical Study of Effect of Intrathecal Use of Alpha-tocopherol on Chronic Vasospasm Hirotoshi Sano, Motoi Shoda, Youko Kato, Kazuhiro Katada, Youichi Shinomiya and Tetsuo Kanno Department of Neurosurgery,
More informationPrimitive reflexes and motor development By T. Akiyama, N. Itoh, R. Suzuki & Y. Kawaguchi Department of Orthopaedic Surgery, Nagasaki University Schoo
Primitive reflexes and motor development By T. Akiyama, N. Itoh, R. Suzuki & Y. Kawaguchi Department of Orthopaedic Surgery, Nagasaki University School of Medicine We studied on the relation between primitive
More informationMicrosoft Word - 「黄砂とその健康影響について」小冊子180323版
...1...1...1...2...4...4...4...6...7...7...7...7...8...8...9...9...10... 11... 11... 11... 11...12...12...13...16...18...20 1 1-1 1-2 1 1 km 24.5 m/s 10 50 m 1 1-3 μm 1-4 1-5 2 8 http://www.jma-net.go.jp/sat/himawari/obsimg/image_dust.html
More information3) Stedmann, E. et al.: Biochem. J., 29; 2107, 1935. 4) Reiss, M.. Hemphill, R. E. E ENature, 161 ; 18, 1948. 5) Tower, D. B. & D. MeEachern: Canada J. Reserch., 27; 105, 120, 132, 1949. 6) Wolleman, M.
More information‰Łflç‘ÇŁ\”ƒ(’FŁª›ð)-A4
1 14163 1611 (2002) 32007 3 3 196 2 1416 ( ) Medsger modified Rodnan total skin thickness score EBM placebo control ACEEBM EBM 3 1611 4 5 (Systemic Sclerosis : SSc) 1980 (1) 1) 200310 (2) 2003 Scl-70 1
More information36:378 第 38 回日本脳卒中学会講演シンポジウム 原著 36: , 要旨 TIA 2 t-pa Key words: stroke registry, stroke subtype, onset-visi
36:378 第 38 回日本脳卒中学会講演シンポジウム 原著 36: 378 384, 2014 1 2 要旨 1999 2012 10 31 29 26 80 30 TIA 2 t-pa Key words: stroke registry, stroke subtype, onset-visit time, chronological change はじめに 4 12 23 27 1 Japan
More informationmrna Zc3h12a IL-6
mrna Zc3h12a IL-6 IgG4 The 4th East Asian Group of Rheumatology (EAGOR2011) S3PE CaMK EBM PubMed NHK TBS European Thyroid Journal Nature, Lancet msv ICRP msv msv msv WHO COE sirna M M M VS VS VS
More informationKey words: bacterial meningitis, Haemophilus influenzae type b, Streptococcus pneumoniae, rapid diagnosis, childhood
Key words: bacterial meningitis, Haemophilus influenzae type b, Streptococcus pneumoniae, rapid diagnosis, childhood Fig.1 Distribution of the cases with bacterial meningitis by age and pathogens Chiba
More information2010 年 6 月 25 表 身体所見 134 cm 31 kg /60 mmhg 83/ ,
24 シンポジウム Ⅲ 要旨 NPPV NPPV 緒 IPF 4 5 1 IPF 2004 2 QOL 179 10 現 10 18 2008 10 言 状 3.4 8.3 76.2 41 37.2 13.6 3 1 症 例 呈 示症例 患者 61 主訴 既往歴 30 45 家族歴 喫煙歴 飲酒歴 職歴 現病歴 13 NSIP 15 1 HOT 15 7 2010 年 6 月 25 表 1 1998
More information1) Asa, S. L., et al.: Immunohistochemical localization of neuron-specific enolase in the human hypophysis and pituitary adenoma, Arch. Pathol. Lab. Med., 108: 40 `43, 1984. 2) Chi, B. H. and Kim, R. C.:
More informationBehçet 病,サルコイドーシス,再発性多発軟骨炎―診断と鑑別を中心にー
58 5 260 270 2015 Behçet Behçet 58 4 Sjögren IgG4 5 Behçet Behçet Behçet 1937 Hulusi Behçet 4 1 25 19,147 HLA B51 A26 2 HLA B51 4 1 Behçet Behçet Behçet Behçet 2 3 Recurrent Aphthous Stomatitis RAS 26
More information_06.indd
30, 35-39, 2010 0.15% 1 C 40 20 1 cm 5 mm WBC 9,400, RBC 259 10 4, Hb 8.5 g/dl, Ht 25.5%, Plt 29 10 4, BUN 116 mg/dl, Cr 7.9 mg/dl, 125 mg/dl, HbA1c 4.3%, ft3 1.97 pg/ml, ft4 1.05 ng/dl, TSH 1.09 μiu/ml,
More informationFig. 1 Chemical structure of TE-031 Code number: TE-031 Chemical name: (-) (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-[(2, 6-dideoxy-3-C-methyl-3-
Fig. 1 Chemical structure of TE-031 Code number: TE-031 Chemical name: (-) (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-[(2, 6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl) oxy]-14-ethyl-12,
More informationmg 8 mg X Cr 9.84 mg/ dl K 1.5 meq/l CK 24,570 U/L Mb 79,530 ng/ml Mb 230,000 ng/ ml AKI 2 IHD IHD 4 IHD
31 1 15 20 2016 15 3 65 5 mg 8 mg 10 15 201X 7 1 11 15 Cr 9.84 mg/ dl K 1.5 meq/l CK 24,570 U/L Mb 79,530 ng/ml Mb 230,000 ng/ ml AKI 2 IHD IHD 4 IHD AKI HD 2004 48 Acute Kidney Injury AKI 48 Cr 0.3 mg/dl
More information_02三浦.indd
36, 7-11, 2016 IPD PCV 5 3 80% 1 invasive pneumococcal disease ; IPD 2010 7 PCV7 2013 13 PCV13 IPD IPD 2,3 2015 1 2015 12 5 1 IPD 2015 1 12 IPD 5 IPD 1 4 2 5 http://pneumocatch.jp/ 5 Statens Serum Institut
More information日赤 No.35☆/7.河相
2 64 2 Mucosa-Associated Lymphoid TissueMALT T γ- 1 Key words T 1 2 64 47 54 60 MALT 63 T MALT 6062-8 63 1 T MALT 63 CHOP 2 35 28 30 28 75 μg 200 mg 20 mg 200 mg 400 mg/80 mg 2 35 mg 1 2 150 mg 200 mg
More information1. Crellin QR, Maccabe JJ and Hamilton EBD: Severe subluxation of the cervical spine in rheumatoid arthritis. J Bone Joint Surg (1970) 52-B, 224-250. 2. Webb FWS, Hickman JA and Brew DStJ: Death from vertebral
More information_14鈴木.indd
35, 66-71, 2015 hairy cell leukemia Hairy cell leukemia HCL : WHO mature peripheral B - cell neoplasma B 1 2% B T 8% 6-10 2 4 hairy cell 5 10 hairy cell leukemia : 74 : : 20 50 57 63 64 73 : : 2003 4 10
More information医学紀要04-瀬戸上.indd
Med. Bull. Fukuoka Univ.39 3/4257 261 2012 A Case of a Neonate with Severe Congenital Toxoplasmosis Takashi SETOUE 1, 2 Eiji OHTA 1, 2 Terufumi GOUSHI 3 1, 2 Shinichi HIROSE 1 Division of Neonatology,
More information72 20 Ope / class Alb g/ cm 47.9kg : /min 112/60m
72 20Ope 68 69 2006 4 50 20 / 52 2006 4 1 2006 4 4 24 class 699.4 5 2 5 23 6 6 15 6 19 6 16 Alb2.03+ 7.5g/ 6 21 153.5cm 47.9kg : 36.7 89/min112/60mmHg (-) (-)S1 S2 S3(-) S4(-) - - 6 15 (+) TP4.9g/dl Alb2.0g/
More information2 章 +αの 情 報 に 着 目 する! 1 血 球 算 定 検 査 結 果 2 生 化 学 検 査 結 果 手 がかりに 乏 しいのも+α 1 症 例 をみてみよう! 1 60 吉 見 祐 輔 1 2 11percutaneous coronary intervention PCI104 38.
2 章 +αの 情 報 に 着 目 する! 1 血 球 算 定 検 査 結 果 2 生 化 学 検 査 結 果 手 がかりに 乏 しいのも+α 1 症 例 をみてみよう! 1 60 吉 見 祐 輔 1 2 11percutaneous coronary intervention PCI104 38.1 130 75mmHg 83 16 SpO 297 1 3 WBCL RBC10 4 L Hb g
More informationJHN CQ 天理よろづ 炎症性筋疾患と自己抗体
1,,,,. 2,. 1,,,. CK 402 U/L, 23.7 U/L, LDH 834 U/L, AST 1,122 U/L, ALT 507 U/L, 1,586 ng/ml Heliotrope Gottron, MRI. Clinical Question ,,,,,,. N Engl J Med 2015;372:1734-47. , 1 / (PM/DM) Bohan&Peter..
More informatione.g., Mahoney, Vandell, Simpkins, & Zarrett, Bohnert, Fredricks, & Randall2010 breadth intensitydurationengagement e.g., Mahone
2014 25 4 453465 1 670 6 1 2 2008, 2009 2002 e.g., 2002; 1999 100 1 2 2013; 2002; 1999 1 2007 2009 2006; 20082006 2013 454 254 e.g., Mahoney, Vandell, Simpkins, & Zarrett, 2009 1 23 2013 Bohnert, Fredricks,
More informationMeasurement of antibodies to double-stranded and single-stranded DNA using bacterio phage Ď DNA as the antigen \ Avidity of antibodies to DNA in pati
Measurement of antibodies to double-stranded and single-stranded DNA using bacterio phage Ď DNA as the antigen \ Avidity of antibodies to DNA in patients with lupus nephritis \ M0T0AKI SAIT0, YASUYUKI
More informationKey words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST
Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST 13) Danaeus, A., Johansson, S. G. O., Foucard, T. & Ohman, S.: Clinical and immunogical aspects of food allergy in childhood.
More informationuntitled
---------- - 1 - ----- 1 Q1 5 Q2 5 Q3 5 Q4 6 Q5 6 Q6 7 Q7 7 Q8 7 Q9 8 Q10 : 8 10 Q1 10 Q2 11 Q3 11 12 Q4 12 Q5 HBs HBc _12 Q6 HBe 12 Q7 13 Q8 NAT 15 Q9 15 Q10 15 Q11 HBs 16 Q12 HBV DNA 16 Q13 17-2 - Q14
More information1_2.eps
第32回 日本頭頸部癌学会ランチョンセミナー6 Pre-Meeting Abstract FDG-PET の頭頸部癌における臨床的有用性 司会 長 放射線治療センター長 講演 1 耳鼻咽喉科 部長 講演 2 PETセンター長 岡村 光英 先生 日時 2008年6月13日 金 12:00 13:00 会場 ハイアットリージェンシー東京 共催 第32回 日本頭頸部癌学会 日本メジフィジックス株式会社 136-0075
More informationmedicaljournal8.pdf
Medical Journal of Aizawa Hospital Vol. 8 (2010) Key words Neuropsychopharmacology Neuroscientist Curr Opin Neurol Clin Rehabil J Neurol Neurosurg Psychiatry J Neurol Neurosurg Psychiatry Lancet
More informationSBP hospitalist network.key
1 Treatment and Prophylaxis of Spontaneous Bacterial Peritonitis (1); (2), (3). (1) (2) (3) :, :, 2 Clinical Question 1 72...,.,,.,... 3. CT..,. 4? SBP? SBP. 5 Clinical Question SBP? SBP,? 6 SBP (Spontaneous
More informationuntitled
NPO Topics Topics 5 74 2008.12.19 2008.12.19 2008.12.19 2008.12.19 2008.12.19 21.3% 2007/6/1 22.1% 2008/9/15 3.9 2.0 2000-2025 51.9% 2006 65 65 60 70% 80% 16.6% 20.6 aging O 2 ml/kg/min(10
More informationCA CA19-9 CA19-9 CA CA CA19-9 ARCHITECT i 2000SR CLIA U/mL CA % CA CA
原 著 30 22-29, 2015 CA19-9 CA19-9 CA19-9 2006 12013 6 CA19-9 32,508 37.0U/mL 790 2 CA19-9 320 CA19-9 ARCHITECT i 2000SRCLIA 0.0 37.0U/mL 8 4 1 2 18CA19-9 198.2 46.4 2,968 U/mL 5 3 2.5% CA19-9 2.5% CA19-9
More informationJ-STAGE 原 著 要旨 5 reversible cerebral vasoconstriction syndrome RCVS posterior reversible encephalopathy syndrome PRES RCVS PRES Key
原 著 1 2 3 2 要旨 5 reversible cerebral vasoconstriction syndrome RCVS posterior reversible encephalopathy syndrome PRES RCVS PRES Key words: pregnancy-associated stroke, cortical subarachnoid hemorrhage,
More information理学療法検査技術習得に向けた客観的臨床能力試験(OSCE)の試行
An Application of an Objective Structured Clinical Examination for Learning Skills in Assessment of Physical Therapy A Task Involving Measurements on the Range of Motion Test Chikako Fujita1) Hiroyasu
More information臨床神経45-1.indb
59 Case of the Issue No. 9 carpal tunnel syndrome: CTS CTS CTS CTS nerve conduction study; NCS needle electromyography; nemg NCS carpal tunnel syndrome: CTS 1 CTS 4 CTS 45 65 1 3 2 CTS CTS 1999 American
More informationCQ 1,.,,.,,...,,,,,,.,,,,,,,MAO 2., 24,. A
CQ 1,.,,.,,...,,,,,,.,,,,,,,MAO 2., 24,. A 15 180 306 7,000 1 3 mg 103 92 89.3 60 60 100 173 28 16.2 3.52.92.3 1.7 1.7 1.7 2 64 78 80 3 ST 4 5 32 6 18 65 CQ 1 307 1 7,000 2006 ; 94 11 : 2149-2168. 2 2010
More informationTable 1 Patients with various renal function * Ccr, Creatinine clearance ml/min per 1. 48 m2 ** C.V.D., Cerebral vascular disease ; C.R F., Chronic renal failure ; H.D., Hemoclialysis ; D., Dialyzer ;
More information胆石症
,. vs 64 .. vs. -, Ransohoff DF, Gracie W. Treatment of gallstones. Ann Intern Med ; 119 : - Halldestam I, Enell EL, Kullman E, et al. Development of symptoms and complications in individuals with asymptomatic
More informationKey words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S.
Key words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S. Table 1. Clinical summary of acute uncomplicated cystitis patients treated with 7432-S UTI : Criteria by the
More information16 MHC 2018; 25 (1) 参加費 1 2, , ,000 会議等 :00 13: :00 13: :20 会場地図 TEL JR 350 m 57
Major Histocompatibility Complex 2018; 25 (1): 56 82 抄録集 16 2018 3 3 7 2 4 43 TEL 06 6962 7001 594 1101 840 TEL 0725 56 1220 56 16 MHC 2018; 25 (1) 参加費 1 2,000 2 1,000 3 3,000 会議等 1 3 3 13:00 13:10 2 3
More information19 8 1970 20 10 4 1
19 8 1970 20 10 4 1 IgE 1960 % 1970 20%, 1990 40% 1998 70% 20 IgE 21 90% IgE IgE (%) 70 60 50 40 30 20 10 0 1970 1975 1980 1985 1990 1995 2000 2005 1. 2005 10 2 30 IgE 2. 3 1. B IgE T IgE IgE IgE 2 T IgE
More information審査報告書(案)
19 83 7 18 628 1 19 8 3 7 18 6 28 30 MI 31 360 21700BZY00247000 5mm CEA 59 mm 2 50% 80 1. 2. 3 19 8 3 [ ] 7 [ ] [ ] [ ] [ ] 18 6 28 [ ] CEA 49mm 50 80 2 4 carotid endarterectomy CEA 1,2 CEA ECST 3 NASCET
More information1 Blood chemistry Peripheral blood Viral marker TP 5.4 g dl WBC 4.310 3 ml Syphilis TPAb Alb 2.7 g dl RBC30210 4 ml HBsAg T. bil 2.3 mg dl Hb 11 g dl
2012; 18: 200 207 Necropsy 1 1 1 2 65 11 autoimmune hepatitisaih 14 21 1 5 13 Necropsy CHF1 A1 Kupffer cell hemosiderin Berlin blue KEY WORDS: hemochromatosis, autoimmune hepatitis, liver cirrhosis, necropsy
More information32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ
29 1 31 40 2014 31 Bisphosphonate related osteonecrosis of jaw; BRONJ 2008 4 2012 3 36 98 8 11 19 BRONJ 0 13 2 5 3 1 1 0 BP 4 15 10 5 α-streptococcus 0 BRONJ BRONJ BP I Paget 1 409-3898 1110 2014 1 27
More information68 22 Proceeding Clinical features and diagnosis of lymphocytic infundibulo-hypophysitis IgG4 12 / 7/ IgG4 3/7 IgG
68 22 Proceeding Clinical features and diagnosis of lymphocytic infundibulo-hypophysitis IgG4 12 /7/5 26 78 2 4 6 11 11 IgG4 3/7 IgG4 2 21 1 1 1 4 4 2 5 3 IgG4 IgG4 IgG4 IgG4 MR 1 Tolosa-Hunt IgG4 2 IgG4
More informationStabilometry-Significance of Locus Length per Unit Area (L/A) in Patients with Equilibrium Disturbances- Tsuyoshi Okawa, Takashi Tokita, Yasunari Shib
Stabilometry-Significance of Locus Length per Unit Area (L/A) in Patients with Equilibrium Disturbances- Tsuyoshi Okawa, Takashi Tokita, Yasunari Shibata Tetsuya Ogawa, Hideo Miyata 1) Department of Otolaryngology,
More information1) Urlne analysls 7)Serologlcal exam. 1 1)ECG W.N.L. sugar 0% CRP (-) urobillnogen N(+) RA (+) 12)Renal function albumin 3(+) ASLO (-) PSP test 15' 40
A case of membranoproliferative glomerulonephritis accompanied with hyper IgM immunodeficiency Kenichiro SHIGEMOTO, Koji WADA, Naoki HAMAGUCHI, Akira HIRABAYASHI, Shunji TOI, Koji USUI, Michiko ARITA,
More informationC/NC : committed/noncommitted
C/NC : committed/noncommitted 110 time post-icd implant 1) The Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report : Effect of encainaide and flecainide on mortality in a
More information1) Delbet P: Retrocissement du choledoque. Cholecysto-duodenostomie. Bull Mem Soc Nat Chir 50: 1144-1146, 1924 2) Wiesner RH, LaRusso NF: Clinicopathologic Features of the Syndrome of Primary Sclerosing
More informationPDFfl[ŁiŠp_Œ{Ł¶…g…fi…{Łt‡«.pdf
診断 治療 技術講座 2018; 29 4 : 413-420 APTT 波形解析 APTT waveform Hideo WADA Key words: APTT, waveform, hemophilia, anticoagulant therapy 1978 1982 1982 1983 1985 NIH 1985 2000 / 2008 1 activated partial thromboplastin
More informationMedical Journal of Aizawa Hospital Medical Journal of Aizawa Hospital Vol. 8 (2010) Key words Neuropsychopharmacology Neuroscientist Curr Opin Neurol Clin Rehabil J Neurol Neurosurg Psychiatry
More information第 14 回血管病理研究会 日時 : 平成 20 年 10 月 10 日 ( 土 ) 会場 : 佐賀大学医学部臨床大講堂 3208 号室会長 : 徳永藏 ( 佐賀大学医学部病因病態科学講座 ) CRP MPO-ANCA 125IU/l CT mpa
第 4 回血管病理研究会 日時 : 平成 20 年 0 月 0 日 ( 土 ) 会場 : 佐賀大学医学部臨床大講堂 3208 号室会長 : 徳永藏 ( 佐賀大学医学部病因病態科学講座 ). 67 2008 CRP MPO-ANCA 25IU/l 009 2 CT mpa GCA PSL 50 mg CRP MPO-ANCA mpa GCA 4 mpa ovarlap 2 TLR 2 2. 対象 方法
More informationuntitled
20 2 14 18 10 16 1 1.0mg 0.035mg 2 1 20 2 14 18 10 16 1 1 1 52 1 1 21 7 28 1 29 2 1 20 1 24 18 10 16 1 1 21 7 28 1 29 1 NET 1.0mg EE 0.035mg *NET *NET 1999 2007 *NET *NET 88 NSAIDs GnRH GnRH NSAIDs 20
More informationJ Life Sci Res 2014; 12: Osaka Prefecture University Journal of Life Science Research Online ISSN
J Life Sci Res 2014; 12: 15-19 2014 Osaka Prefecture University Journal of Life Science Research Online ISSN 2186-5809 583-8555 3-7-30 577-8567 3-1-1 2014 9 11 2014 10 21 Exposure mild-level LED light
More informationMRI demonstrates brain edema due to hyperperfusion with NCSE 39:447 CT MRI 7 DWI ADC-map FLAIR DWI Fig. 1 MRA 2 MRI DWI ADC-map FLAIR Fig. 2 3 FLAIR F
39:446 症例報告 39: 446 450, 2017 MRI 1 1 2 3 要旨 84 MRI 2 MRI ADC-map FLAIR 3 ASL MRA MCA 16 MRI MRI ASL Key words: nonconvulsive status epilepticus, mimicking cerebral infarction, magnetic resonance imaging,
More information明海大学歯学雑誌 37‐2/1.秦泉寺
J Meikai Dent Med 37, 153 158, 8 153 1 7 5ml /1 min Wong-Baker Face Rating Scale FS 5 1 9. g 3 5ml /1 min, FS 1 66 6ml /1 min FS 5 1 9. g 3 6ml /1 min, FS 3 Two Cases of Xerostomia that Showed an Improvement
More information000 001
all-round catalogue vol.2 000 001 002 003 AA0102 AA0201 AA0701 AA0801 artistic brushes AA0602 AB2701 AB2702 AB2703 AB2704 AA0301 AH3001 AH3011 AH3101 AH3201 AH3111 AB3201 AB3202 AB2601 AB2602 AB0701 artistic
More informationEVALUATION OF MAGNETIC RESONANCE IMAGING (MRI) IN DIAGNOSIS OF ACOUSTIC NEUROMA-COMPARATIVE STUDY WITH PLAIN X-RAY AND CTS- KIMIHISA NOMURA, M.D., MAK
EVALUATION OF MAGNETIC RESONANCE IMAGING (MRI) IN DIAGNOSIS OF ACOUSTIC NEUROMA-COMPARATIVE STUDY WITH PLAIN X-RAY AND CTS- KIMIHISA NOMURA, M.D., MAKOTO SAKAI, M.D., ATSUSHI SHINKAWA, M.D. and HIROSATO
More informationCRA3689A
AVIC-DRZ90 AVIC-DRZ80 2 3 4 5 66 7 88 9 10 10 10 11 12 13 14 15 1 1 0 OPEN ANGLE REMOTE WIDE SET UP AVIC-DRZ90 SOURCE OFF AV CONTROL MIC 2 16 17 1 2 0 0 1 AVIC-DRZ90 2 3 4 OPEN ANGLE REMOTE SOURCE OFF
More informationE3200 BV FOLFOX4 FOLFOX4 PFS % 0.42, 0.65 p< log-rank % FOLFOX4 8.6% FOLFOX % FOLFOX4 259/ % FOL
E3200 BV FOLFOX4 FOLFOX4 PFS 4.5 7.5 0.518 95% 0.42, 0.65 p
More information日本職業・災害医学会会誌第51巻第5号
太田ら 同時多発性高血圧性脳葉出血の 1 手術例 図 1 搬入時 CT 上段 単純 CT 下段 造影 CT 図 2 術後の脳血管撮影検査では明らかな出血源は認めない 379 Reprint request: MULTIPLE SIMULTANEOUS HYPERTENSIVE LOBAR HEMORRHAGE Hirotsugu OHTA M.D. 1) and Akira YOKOTA M.D.
More informationE Societe de Pathologie Infectieuse de Langue Francaise (, 1991) E Spanish Thoracic Society (1992) E American Thoracic Society (ATS : 1993. ü ù2001 ) E British Thoracic Society (1993, ü è2001 ) E Canadian
More informationVol.1_No.2_Dec.2012.book
1 2 55 60 (2012 ) 2 2 1 Glenn 30 CRP 2 28 CRP CRP 1 hypertrophic osteoarthropathy, cyanosis, congenital heart disease (hypertrophic osteoarthropathy HOA) 3 HOA 2 30 {S,L,L}, 18 20 3 7.1mg/dL 2 178cm 60kg
More information小児感染免疫第27巻第4号
364 2015 C 1 2 3 4 5 6 7 8 urinary tract infection UTI 2 1 UTI 1 3 5 2,3 4 1 UTI Escherichia coli E. coli 80 5 Enterococcus 1 UTI 83 78 53 98 5 WBCs HPF 73 81 81 83 or 93 72 ororor 99.8 70 4 Key words
More informationCHEMOTHERAPY APRIL 1992 Table 2. Concentration of meropenem in human prostatic fluid Table 1. Background of 21 chronic complicated UTI cases * NB + BPH, NB + Kidney tumor, NB + Kidney tuberculosis Table
More information研究成果報告書(基金分)
RA RF ACPA RA RA RA RA RA IC IC RA RA IC RA IC RA IC RA RA RA IC 1 RA OA RA RA OA WinROOF RT-PCR ELISA RA RA RA OA 1 2 Thrombospondin-1 TSP-1 Platelet factor 4 PF-4RA RA RA RA 2 2 TSP-1 TSP-1 SS SLE RF
More information01.浅野.ppt
2010 14 23 1 15 2010 the 74 th Annual Scientific Meeting of American College of Rheumatology November 7 11, 2010 at Georgia World Congress Center, Atlanta, GA, USA 2284 SSc 142 Plenary Session: 3 Concurrent
More information終末期の呼吸困難症状への対応*松坂最終修正
Clinical Question 2017 5 27 1 PCOC 1. 12778 ( 55%, 45% NRS. 1 54, 35%. NRS. NRS,,,,,,,, Performance status, Ekstrom, M., et al.2016 J Pain Symptom Manage 51(5):816-23. . 1 85 ADL. 3,,,,. JCS200,, 40 /,
More information1) Michaelis L. Biochem Z., 59, 78, 1914. 2) Ferris H. C. Dent. Cosmos Phila., 63, 10, 93, 1921. 3) Bloomfield A. L. Bull Johns Hopk. Hosp. Bait., 31, 118, 1920. 4) Starr H. C. J. Biol. Chem. Bait., 54,
More informationTable 1 ICHs in young adults Table 2 Five cases of undetermined etiology
Table 1 ICHs in young adults Table 2 Five cases of undetermined etiology 神 1 1. left : in the right ted MRI, callosum. parietal. right : ICH in 保 洋 之 他 ICHs 4 Ti-weighthe 1. left: rrhagic corpus infarction
More informationCore Ethics Vol. : - NICU : : - A B C D
Core Ethics Vol.,NMR...... Core Ethics Vol. : - NICU : : - A B C D b: Duff and Campbell A B C: D : a B C b Core Ethics Vol. : -, : C D :.. D.. bd D CD AB CD : Duff C b C B : Core Ethics Vol. C D B A D
More information